Literature DB >> 11888452

Treatment of postoperative peritonitis of small-bowel origin with continuous enteral nutrition and succus entericus reinfusion.

B Calicis1, Y Parc, S Caplin, P Frileux, N Dehni, J-M Ollivier, R Parc.   

Abstract

HYPOTHESIS: Proximal intestinal stomas established by the exteriorization of leaking anastomosis in the presence of peritonitis can be used to reinfuse succus entericus and provide adequate enteral nutrition.
DESIGN: Retrospective analysis of prospectively gathered data from a cohort of consecutive patients admitted between January 1993 and December 1999 for postoperative peritonitis requiring laparotomy and the construction of one or more small-bowel stomas.
SETTING: Tertiary referral center with a surgical intensive care unit experienced in the treatment of intra-abdominal sepsis and succus entericus reinfusion. PATIENTS: Twenty-one consecutive patients with postoperative peritonitis originating from a jejunal or ileal leak. We excluded patients with established enterocutaneous fistulae, abscesses amenable to percutaneous drainage or other conservative treatments, and postoperative peritonitis caused by ileocolic or ileorectal anastomosis.
INTERVENTIONS: Early laparotomy with exteriorization of small-bowel leak(s), and continuous enteral nutrition (CEN) and succus entericus reinfusion (SER) via the distal portion of the stoma until gastrointestinal continuity was restored. MAIN OUTCOME MEASURES: Feasibility of CEN and SER with temporary, diverting small-bowel stomas and their associated postoperative morbidity and mortality rates.
RESULTS: One patient died, and 14 experienced complications. For technical reasons, CEN and SER were discontinued early on in 7 patients. The mean duration of CEN and SER was 58 days and 61 days, respectively. Enteral feedings allowed the suppression of central venous access after a median of 28 days, with 82 days as a median time to restoration of intestinal continuity.
CONCLUSIONS: Although the exteriorization of small-bowel leaks with CEN and SER is generally feasible and effective in the treatment of critically ill patients with peritonitis secondary to small-bowel leaks, it is associated with significant morbidity and mortality, in part relating to patients' underlying diseases.

Entities:  

Mesh:

Year:  2002        PMID: 11888452     DOI: 10.1001/archsurg.137.3.296

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  6 in total

Review 1.  The challenge of post-operative peritonitis after gastrointestinal surgery.

Authors:  Massimo Sartelli; Ewen A Griffiths; Maurizio Nestori
Journal:  Updates Surg       Date:  2015-08-12

Review 2.  The potential role for xanthine oxidase inhibition in major intra-abdominal surgery.

Authors:  Anubhav Mittal; Anthony R J Phillips; Benjamin Loveday; John A Windsor
Journal:  World J Surg       Date:  2008-02       Impact factor: 3.352

3.  Postoperative Peritonitis After Digestive Tract Surgery: Surgical Management and Risk Factors for Morbidity and Mortality, a Cohort of 191 Patients.

Authors:  Thierry Bensignor; Jérémie H Lefevre; Ben Creavin; Najim Chafai; Thomas Lescot; Thévy Hor; Clotilde Debove; François Paye; Pierre Balladur; Emmanuel Tiret; Yann Parc
Journal:  World J Surg       Date:  2018-11       Impact factor: 3.352

4.  Factors related to anastomotic dehiscence and mortality after terminal stomal closure in the management of patients with severe secondary peritonitis.

Authors:  José L Martínez; Enrique Luque-de-León; Pablo Andrade
Journal:  J Gastrointest Surg       Date:  2008-10-16       Impact factor: 3.452

5.  Continuous reinfusion of succus entericus associated with fistuloclysis in the management of a complex jejunal fistula on the abdominal wall.

Authors:  Adriano M Pflug; Edivaldo M Utiyama; Belchor Fontes; Mario Faro; Samir Rasslan
Journal:  Int J Surg Case Rep       Date:  2013-05-23

6.  Short Bowel Syndrome in an Extremely Low Birth Weight Premature Infant with Wernicke Encephalopathy: A Case Report.

Authors:  Yanzhen Zhang; Bo Zhou; Lanyan Wu; Hong Cao; Guozhong Xie; Hua Fang
Journal:  Am J Case Rep       Date:  2020-10-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.